What does Rayzebio, Inc. do?

Jun 22 2025 07:24 PM IST
share
Share Via
Rayzebio, Inc. is a small-cap biotechnology company with a market cap of approximately $3.81 billion, currently reporting a net profit loss of $18 million as of September 2023. The company has no dividend yield and negative key financial metrics, including a debt equity ratio of -0.94 and a return on equity of -11.92%.
Overview:
Rayzebio, Inc. operates in the biotechnology industry and is classified as a small-cap company.

Financial Snapshot:
Net Profit: -18 Million (Quarterly Results - Sep 2023)
Market cap: USD 3,814.02 Million (Small Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.94
Return on Equity: -11.92%
Price to Book: 6.63

Contact Details:
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Rayzebio, Inc.?
Jun 22 2025 06:33 PM IST
share
Share Via